VSV-hIFNβ-NIS

vesicular stomatitis virus-based vaccine expressing IFN-β and NIS · Mayo Clinic

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VSV-hIFNβ-NIS, covering 2026-04-13 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma [Phase 1]

See pricing